The soluble guanylate cyclase activator BAY 58-2667 protects against morbidity and mortality in endotoxic shock by recoupling organ systems

Ítems similars

• The Soluble Guanylate Cyclase Activator BAY 58-2667 Protects against Morbidity and Mortality in Endotoxic Shock by Recoupling Organ Systems
  per: Vandendriessche, Benjamin, et al.
  Publicat: (2013)
• Pharmacological preconditioning with the guanylate cyclase activator cinaciguat (BAY 58-2667) protects against reperfusion injury after cardiopulmonary bypass
  per: Radovits, Tamás, et al.
  Publicat: (2009)
• Antiplatelet effects of aspirin are not affected by the soluble guanylate cyclase activator cinaciguat (BAY 58-2667)
  per: Frey, Reiner, et al.
  Publicat: (2011)
• Relaxant effect of BAY 41-2272 and BAY 58-2667 in the gastrointestinal tract of apo-sGC mice
  per: Cosyns, Sarah, et al.
  Publicat: (2011)
• The Soluble Guanylyl Cyclase Activator Bay 58-2667 Selectively Limits Cardiomyocyte Hypertrophy
  per: Irvine, Jennifer C., et al.
  Publicat: (2012)